HOLD with 4-5% position cap and $175 hard stop; wait for confirmed close above 200.20 with volume expansion and MACD reclaiming its signal line

• 200 SMA at 200.20 vs current price at 193.12 creates $7 overhead supply that has been defended since January
• MACD histogram turned negative at upper Bollinger band resistance with RSI at 68 on lighter volume—textbook momentum divergence setup
• Forward EPS of $14.66 required for bull case; market assigning 13x P/E vs historical ~25x suggests skepticism
• Goodwill and intangibles of $27.8 billion (40% of total assets) from M&A binge create impairment risk if GenAI disrupts legacy model
• 3.47% dividend yield does not cushion a 60% drawdown; prior stock fell from $291 to $118
• 89% probability of no Fed cuts through 2026 compresses multiples for high-duration consulting revenue
• 40%-plus of revenue from non-US operations faces European inflation re-acceleration risk
• ATR at $6.82, band width at 13.5% of price, beta 1.07 support 4-5% position sizing maximum
• $175 stop is roughly 9% below current price; failed 200 SMA test risks mean-reversion to midline at $182.62 (5.5% drawdown)
• Binary earnings catalyst in three weeks; breakout failure is higher probability given divergence, lighter volume, and resistance

→ vs aggressive: 200 SMA 'ripped through' in 2022 argument is survivorship bias—the prior setup was established uptrend with 200 SMA as support during a multi-year regime; current setup is a stock that experienced 60% drawdown trying to reclaim after regime change

→ vs aggressive: MACD at -0.15 dismissed as 'noise' is dangerous reasoning; this histogram turned negative into the single most important resistance level on the chart, not during a coherent new uptrend like July's brief negative print

→ vs aggressive: 'Asymmetric reward to risk' math is anchored on assumptions that could break—2-to-1 ratio collapses to roughly 1-to-1 if EPS lands at $13 instead of $14.66, which is within plausible outcomes given GenAI transition risk

→ vs aggressive: 'Paid to wait' dividend framing is the most dangerous argument—3.47% yield does not cushion a 60% drawdown; market is pricing in capital risk, not rewarding patience

→ vs aggressive: Nvidia-Hugging Face deal as tailwind cannot be claimed while dismissing European inflation risk; macro factors must be weighed in the same analytical frame

→ vs aggressive: Position sizing at 4-5% labeled 'too conservative' is backwards—technical report explicitly recommends reducing size by ~30% given unnormalized volatility; ATR $6.82, band width 13.5%, and beta 1.07 do not support larger allocation

→ vs aggressive: HOLD framed as 'being early' with breakout 'piling in' ignores that failed test mean-reverts to $182.62 midline, eating into the stop zone before anyone reacts

HOLD at 4-5% allocation with structural stop at 180-182, no preemptive trim, no additions until breakout confirmation above 200.20, and 25-35% trim into Q4 earnings

• PEG of 0.78 is circular math using consensus forward EPS that the market has already discounted at current 13x-17x multiple
• 3.47% dividend combined with 5 billion annual buybacks provides real per-share economics that compound regardless of price movement
• MACD momentum divergence signal (-0.15 histogram at upper Bollinger with RSI 68) indicates losing upside thrust, not reversal; argues for tightening stops not trimming
• Goodwill of 27 billion (40% of assets) is mostly already written down at 3.71x book; impairment risk is non-cash and already discounted
• Stock at 193 has already priced in much of the 89% no-Fed-cut scenario; remaining discount rate compression risk is real but not dominant
• Position sizing at 4-5% is correct given 6.82 ATR, 13.5% band width, three weeks to binary catalyst, and unresolved technical risk
• Stop at 175 (9% below price, only 3% above panic low) is too tight and risks being triggered on routine mean-reversion to Bollinger midline at 182.62
• Breakout confirmation trigger: close above 200.20 on volume with MACD reclaiming signal line
• Trim trigger: close back below 10 EMA at 187 with MACD continuing to deteriorate, confirming 200 SMA test failure

→ vs aggressive: PEG of 0.78 is circular; low multiple IS the market's verdict that it doesn't believe 17% growth; 2-to-1 reward-to-risk collapses if forward EPS lands below 14 dollars

→ vs aggressive: Dismissal of -0.15 MACD as noise is too cavalier; histogram turning negative at upper Bollinger with RSI 68 IS a coherent momentum divergence signal

→ vs conservative: Stop at 175 is too tight and will trigger on routine pullback to 182.62 midline, stopping out right before catalyst resolves bull-bear debate

→ vs conservative: 200 SMA framing assumes the line is permanent; 50 SMA rising 3.5% per week and price above all short-term trend gauges is also information

→ vs conservative: ACN is a services integrator, not an AI pure-play; IT spending cuts hurt it, not AI narrative fragility

→ vs conservative: Failed test at 200.20 doesn't mean stock goes to 160; it means consolidation and retest, not clean reversal